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Functional outcomes of acutely infected knee 
arthroplasty: a comparison of different surgical 
treatment options
Background: An infected total knee arthroplasty (TKA) can be treated with irrigation 
and débridement with polyethylene exchange (IDPE) or a 2-staged revision (2SR). 
Although research has examined infection eradication rates of both treatments, patient 
outcomes have not been reported. We examined patient-reported outcomes following 
treatment compared with matched, noninfected controls.
Methods: We retrospectively identified patients with infected TKAs who had undergone 
the index procedure between May 1991 and November 2011. Patient-reported outcomes 
included the 12-item Short Form Health Survey, Western Ontario and McMaster Uni-
versities Arthritis Index, and Knee Society Scores as well as range of motion. Patients with 
noninfected primary TKAs matched by age and age-adjusted Charlson Comorbidity 
Index score were used as controls. Intention-to-treat groups of 2SR and IDPE were used, 
with the IDPE group subdivided into successful and unsuccessful groups.
Results: We included 145 patients with infected TKAs with mean follow-up of 
64.2 months and 145 controls with a mean follow-up of 35.4 months in our analysis. Out-
comes of the controls and the successful IDPE groups were equivalent. The 2SR cohort 
had lower scores in all categories than controls. There was a 39% success rate in eradicat-
ing infection with IDPE. Patients in whom IDPE failed had lower scores in all categories 
than controls. There was no difference between the failed IDPE group and the 2SR group.
Conclusion: Controversy regarding treatment options for acutely infected TKA has 
been focused on infection eradication. However, functional outcomes following treat-
ment need to be taken into consideration. Patients whose infections were successfully 
treated with IDPE had equivalent outcomes to controls.
Contexte : Il est possible de traiter une arthroplastie totale du genou (ATG) infectée par 
irrigation et débridement avec changement du polyéthylène (IDCP) ou par une révision 
en 2 étapes. Même si la recherche a examiné les taux d’éradication de l’infection au 
moyen des 2 traitements, les résultats chez les patients n’ont pas fait l’objet de rapports. 
Nous avons comparé les résultats enregistrés chez les patients traités à ceux de témoins 
assortis non infectés. 
Méthodes : Nous avons recensé de manière rétrospective les patients qui ont présenté 
une infection de leur ATG et qui avaient initialement subi leur intervention entre mai 
1991 et novembre 2011. Les résultats rapportés par les patients incluaient le questionnaire 
SF (Short Form) sur la santé en 12 points, l’indice WOMAC (établi par les universités 
Western Ontario et McMaster), le score de la Knee Society, de même que l’amplitude de 
mouvement. Des patients soumis à une ATG primaire non infectée assortis selon l’âge et 
le score de comorbidités de Charlson ajusté selon l’âge ont servi de participants témoins. 
On a réparti les groupes selon l’intention de traiter par révision en 2 étapes ou par IDCP; 
le groupe IDCP a été subdivisé selon que l’intervention avait réussi ou non. 
Résultats : Notre analyse a regroupé 145 patients dont l’ATG s’était infectée et qui ont 
été suivis en moyenne pendant 64,2 mois, et 145 témoins suivis en moyenne pendant 
35,4 mois. Les résultats ont été équivalents chez les témoins et les groupes dont l’IDCP 
avait réussi. La cohorte soumise à la révision en 2 étapes a obtenu des scores moindres 
dans toutes les catégories, comparativement aux témoins. On a noté un taux de succès de 
39 % pour l’éradication de l’infection avec l’IDCP. Les patients chez qui l’IDCP a 
échoué présentaient des scores moindres dans toutes les catégories comparativement aux 
témoins. On n’a noté aucune différence entre le groupe chez qui l’IDCP avait échoué et 
le groupe soumis à la révision en 2 étapes. 
Conclusion : La controverse quant aux options thérapeutiques pour les infections aiguës 
d’ATG portait sur l’éradication de l’infection. Or, les résultats fonctionnels après le traite-
ment devraient aussi entrer en ligne de compte. Chez les patients dont les infections ont 
été traitées avec succès par IDCP, les résultats ont été équivalents à ceux des témoins. 
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P eriprosthetic joint infection is a devastating compli-cation after total knee arthroplasty (TKA). Between 2005 and 2006, 25% of revisions were to manage 
infection.1 Demand for primary TKA in the United States 
is projected to grow by 673% to 3.48 million procedures 
by 2030.2 This would translate into a huge number of 
patients experiencing periprosthetic joint infections, with 
the care of these patients representing a substantial finan-
cial burden to society. The surgical options for treatment 
of periprosthetic infection include irrigation and débride-
ment with polyethylene exchange (IDPE), single-stage 
revision, or 2-stage revision (2SR).
Irrigation and débridement with polyethylene exchange 
is an attractive alternative for both patient and surgeon. 
Compared with a 2SR, benefits of an IDPE include reten-
tion of implants, preservation of bone stock, shorter pro-
cedure duration, less chance of intraoperative fracture 
from removal of components and implantation of cement 
spacers, and faster postoperative rehabilitation.3–5 How-
ever, the reported success rate of IDPE is variable, with 
reports ranging from 29% to 83%.6–10 By comparison, 
2SR is considered the gold standard, with success rates 
reported in the range of 75%–100%.11–17 In addition, it 
has been reported that failure rates of 2SR for TKA infec-
tions are higher in patients treated with previous IDPE 
than in patients who did not receive IDPE.18 Therefore, 
surgeons considering IDPE need to balance potential 
benefits of the procedure with the lower eradication rate 
and potentially decreased chance of eradication should the 
patient ultimately receive 2SR.
There may be a role for IDPE in certain situations, such 
as the treatment of acute postoperative and acute hemato-
genous infections.19 An acute postoperative infection has 
been defined as one that occurs within the first 4 weeks after 
index TKA.20 Other studies are more reserved in their rec-
ommendations and state that IDPE should be consider ed 
only in immunologically optimized patients with acute non-
Staphylococcal infections.21 Although there is an abundance 
of literature studying the successful eradication rates with 
IDPE and 2SR, there is a paucity of data reporting on the 
patient experience or patient satisfaction associated with 
these revision procedures. Understanding patient-reported 
satisfaction is important to the treatment decision process. 
Therefore, the purpose of this study was to examine patient-
reported outcomes in patients with infected TKAs based on 
whether the patients were treated with initial 2SR, successful 
IDPE, or failed IDPE with subsequent 2SR; to compare 
each of the above cohorts to a matched control group of 
patients with noninfected TKAs; and to determine the suc-
cess rates of 2SR and IDPE in our study population.
Methods
After obtaining institutional review board approval, we 
performed a database query to identify patients whose 
index TKAs, performed between May 1991 and Novem-
ber 2011, were acutely infected. Inclusion criteria for our 
retrospective review were a minimum 1-year follow-up 
after surgical treatment of infection. 
All procedures were performed by 1 of 7 surgeons at 
our institution. All 7 are high-volume, arthroplasty 
 fellowship–trained surgeons. Implant type for the index 
procedures included varying levels of constraint, includ-
ing posterior stabilized, varus-valgus constrained non-
hinged, and hinged knees.
In 2011, The Musculoskeletal Infection Society created 
guidelines for the diagnosis of periprosthetic joint infection 
(PJI). A definite diagnosis of PJI can be made when the fol-
lowing conditions are met.22
• Sinus tract communicating with the prosthesis.
• Pathogen isolated by culture from 2 separate tis-
sue or fluid samples obtained from the affected 
prosthetic joint.
• Presence of at least 4 of the following: elevated 
serum erythrocyte sedimentation rate (ESR) or 
serum C-reactive protein (CRP) concentration, 
elevated synovial white blood cell count, elevated 
synovial neutrophil percentage, presence of puru-
lence in the affected joint, isolation of a micro-
organism in 1 culture of periprosthetic tissue or 
fluid, and more than 5 neutrophils per high-
power field in 5 high-power fields observed from 
histologic analysis of periprosthetic tissue at ×400 
magnification.
At our institution, diagnosis of infection follows these 
criteria, with the whole clinical picture used to guide 
treatment. Threshold values for ESR and CRP in the 
present study were are 30 mm/hr and 10 mg/L, respect-
ively. We excluded patients with less than 1 year of com-
plete follow-up.
Identified patients were matched to a control cohort 
of patients with noninfected primary TKAs based on 
age and the age-adjusted Charlson Comorbidity Index 
(CCI) score. The CCI score is a validated method of 
estimating risk of death from comorbid disease and has 
also been found to correlate well with major complica-
tions in revision surgery.23,24 Patients with a surgically 
managed infected TKA were then divided into either 
the 2SR or IDPE group based on intention to treat. The 
type of treatment performed was at the discretion of the 
treating surgeon. The IDPE group was then further 
subdivided based on whether the IDPE was successful 
or unsuccessful at eradicating infection; patients in 
whom IDPE was not successful required subsequent 
2SR. Both acute hematogenous and acute postoperative 
infections were defined as those presenting within 
4 weeks of onset of symptoms. We considered the infec-
tion to be eradicated when the inflammatory markers 
had normalized, the clinical symptoms had improved 
and the surgical wound had healed.
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Functional outcomes and reoperations associated with 
unsuccessful eradication of infection were reviewed. We 
used the most recent patient-reported scores and range 
of motion (ROM) for analysis. For patients who had 
unsuccessful IDPE and required subsequent 2SR, clinical 
outcomes were measured at their most recent follow-up 
(i.e., after their 2SR). We calculated CCI scores based on 
a review of patient charts. At each clinic visit, ROM was 
recorded using a goniometer; ROM at the initial visit 
and at latest review was used in this study. Western 
Ontario and McMaster Universities Arthritis Index 
(WOMAC), Knee Society Clinical Rating System (KSS) 
and the 12-item Short-Form Health Survey (SF12) 
scores were recorded from standardized forms that are 
routinely used for all arthroplasty patients at our institu-
tion. All 3 scores have been validated for use in quantify-
ing knee pain and function.25–27 
Statistical analysis
We used the Statistical Package for the Social Sciences 
(SPSS Inc.) for the statistical analysis. We used the Stu-
dent t test for parametric comparisons and the Mann–
Whitney U test for nonparametric comparisons between 
the groups. The Mann–Whitney U test was used when 
data for a particular variable did not meet the distribution 
assumptions required by their parametric counterpart.
Results
During our study period, 1857 knee revisions were per-
formed at our institution. Review of our database identi-
fied 145 infected TKAs in 145 patients. Of the 
145 patients with infected TKAs, 91 were treated initially 
with 2SR and 54 were treated with IDPE. Of the 
91 patients treated with 2SR, 79 had successful eradication 
of infection and 12 had reoperations for infection. Of the 
54 patients treated with IDPE, 21 had successful infection 
eradication and 33 had a persistent infection and required 
2SR (Fig. 1). All of the patients in our cohort in whom 
IDPE failed received a subsequent 2SR. Of the 21 patients 
in whom IDPE was successful, 9 had their infections diag-
nosed during the acute postoperative period and 12 had 
diagnoses of acute hematogenous infection. Of the 
33 patients in whom IDPE was unsuccessful, 4 had their 
infections diagnosed during the acute postoperative 
period and 29 patients had diagnoses of acute hemato-
genous infection (Fig. 1). In other words, acute postopera-
tive infection in our patient cohort represented 43% of 
successful IDPE and 12% of failed IDPE. 
There was no difference in age, CCI scores or body mass 
index between controls and patients with infected TKAs 
(Table 1). Mean clinical follow-up for patients with infected 
TKAs was 64.2 (range 12–237) months compared with 35.4 
(range 24–120) months in the control group (p < 0.001; 
Table 1). 
For the successful IDPE cohort, 6.7% of patients had a 
hinged prosthesis and 93.3% had posterior stabilized pros-
theses. All patients in the failed IDPE group had posterior 
stabilized prostheses. In the 2SR group, 6.1% had a hinged 
prosthesis, 57.3% had varus-valgus constrained prostheses, 
and 36.6% had posterior stabilized prostheses. The mean 
duration from initial arthroplasty surgery to the 2SR was 
31.7 (range 2–180) months. The mean duration from  initial 
Fig. 1. Distribution of patients based on treatment algorithm. 2SR = 2-staged revision; IDPE = irrigation 
and débridement with polyethylene exchange. 
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arthroplasty to successful IDPE was 15.3 (range 1–89) 
months. Finally, the mean duration from initial arthroplasty 
to failed IDPE was 23.8 (range 1–120) months.
Compared with the 2SR group, the control group per-
formed better on all measures, with better SF12 mental 
composite scale (p = 0.005), SF12 physical composite scale 
(p = 0.002), WOMAC (p < 0.001) and KSS (p < 0.001) 
scores and improved ROM (p < 0.001) at latest review 
(Table 2). When the 2SR group was divided into success-
ful and failed 2SR, the control group performed better 
than both on all measured outcomes (all p < 0.05). Simi-
larly, the control group performed better on all measures 
than the failed IDPE group (all p < 0.05; Table 3). Com-
paring the failed IDPE group with the 2SR group revealed 
no difference in any outcome (all p > 0.05; Table 4). Com-
paring the control group with the successful IDPE group 
demonstrated no difference in any measured outcome (all 
p > 0.05; Table 5). The success rate with IDPE was 39% 
and the success rate with 2SR was 87% in our cohorts.
Discussion
Periprosthetic joint infection continues to be a challenge in 
TKA for both patients and surgeons. Twenty-fice percent 
of revisions are done as a result of infection,1 with an inci-
dence rate of 1% for TKA.28 The optimal treatment for 
patients with infected TKAs is controversial. While 2SR 
remains the gold standard in treatment with an eradication 
rate ranging from 75% to 100%,11–17 there is no clear con-
sensus on the role of IDPE in the treatment of peripros-
thetic infection. Compared with 2SR, the benefits of IDPE 
include retention of implants with preservation of bone 
stock, shorter procedure durations, decreased chance of 
intraoperative fracture from removal of components with 
implantation of cement spacers, and faster postoperative 
rehabilitation.3–5 The main arguments against the use of 
IDPE as a treatment option have centered on its low suc-
cess rate at eradicating infection and on the possibility that 
IDPE may reduce the success rate of a subsequent 2SR.18 
There is an abundance of literature on the treatment of an 
infected TKA with success rates of IDPE reported to 
range from 29% to 83%.6–10 Therefore, we elected not to 
focus on success or failure rates of eradication. Instead, the 
aim of the present study was to add to the body of litera-
ture by being, to our knowledge, the first study to focus on 
patient-reported outcomes based on treatment provided.
Our results demonstrate that there is no difference in 
patient-reported clinical outcomes when comparing 
Table 1. Patient demographic and clinical characteristics
Group; mean
Characteristic Control Infection p value
Age, yr 67.7 68.9 0.21
CCI score 1.51 1.65 0.49
BMI 32.8 33.1 0.84
Follow-up, mo 35.4 64.2 < 0.001
BMI = body mass index; CCI = Charlson Comorbidity Index.
Table 2. Outcome scores comparing controls with patients 
with infected TKAs who received a 2SR
Group; mean
Outcome measure Control 2SR p value
SF12 mental component score 53.4 49.7 0.045
SF12 physical component score 38.9 33.8 0.002
KSS 169.3 135.3 < 0.001
WOMAC 78.1 62.8 < 0.001
ROM, arc 116.9 91.1 < 0.001
2SR = 2-staged revision; KSS = Knee Society score; ROM = range of motion; SF12 = 
12-item Short Form Health Survey; TKA = total knee arthroplasty; WOMAC = Western 
Ontario and McMaster Universities Arthritis Index.
Table 3. Outcome scores comparing controls with patients 
with infected TKAs in whom IDPE failed
Group; mean
Outcome measure Control Failed IDPE p value
SF12 mental component score 53 46.1 0.026
SF12 physical component score 42.5 37.3 0.045
KSS 170.4 142.1 0.004
WOMAC 76.2 63.9 0.036
ROM, arc 116.6 93.6 0.003
IDPE = irrigation and débridement with polyethylene exchange; KSS = Knee Society 
score; ROM = range of motion; SF12 = 12-item Short Form Health Survey; TKA = total 
knee arthroplasty; WOMAC = Western Ontario and McMaster Universities Arthritis Index.
Table 5. Outcomes comparing controls with patients with 
infected TKAs in whom IDPE was successful
Group; mean
Outcome measure Control Successful IDPE p value
SF12 mental component score 49.4 50.1 0.96
SF12 physical component score 37.2 37.7 0.93
KSS 160.8 150.1 0.48
WOMAC 75.6 72.1 0.67
ROM, arc 109 110.9 0.56
2SR = 2-staged revision; IDPE = irrigation and débridement with polyethylene exchange; 
KSS = Knee Society score; ROM = range of motion; SF12 = 12-item Short Form Health 
Survey; TKA = total knee arthroplasty; WOMAC = Western Ontario and McMaster 
Universities Arthritis Index.
Table 4. Outcome scores comparing failed IDPE with 2SR
Group; mean
Outcome measure Failed IDPE 2SR p value
SF12 mental component score 45.2 49.7 0.08
SF12 physical component score 37.2 33.8 0.12
KSS 141.8 135.3 0.54
WOMAC 63.9 62.8 0.93
ROM, arc 93.4 91.1 0.47
2SR = 2-staged revision; IDPE = irrigation and débridement with polyethylene exchange; 
KSS = Knee Society score; ROM = range of motion; SF12 = 12-item Short Form Health 
Survey; TKA = total knee arthroplasty; WOMAC = Western Ontario and McMaster 
Universities Arthritis Index.
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 unsuccessful IDPE and 2SR. Most interestingly, we found 
no difference in any outcome when comparing the control 
group with the successful IDPE group. These findings are 
important when counselling a patient on the treatment 
options available for an infected TKA. The improved satis­
faction of a successful IDPE must be weighed against the 
lower rates of successful eradication, and these issues need 
to be discussed with the patient.
In our cohort, IDPE resulted in an eradication rate of 
39%, which is consistent with rates reported in the litera­
ture.6–10 Similarly, the eradication rate after 2SR in our 
cohort was 87%, which is also consistent with published 
rates.11–17 Treatment with IDPE is more likely to be suc­
cessful in cases of acute postoperative and acute hemato­
genous infections.19 The failed IDPE group in our study 
had a greater proportion of acute hematogenous infection 
than the successful IDPE group. It is possibile that some of 
our patients in whom IPDE failed actually had misdiag­
nosed chronic infections. However, the 39% eradication 
rate in our study is consistent with that reported in previ­
ous studies evaluating IDPE for infected TKAs.6–10 Fur­
thermore, the main purpose of the present study was to 
report on outcomes based on the treatment patients 
received rather than the success or failure of eradication.
Limitations
The study limitations were as follows. First, this study 
involved a retrospective review and was therefore subject 
to all the biases associated with this type of study design. 
Second, some patients in whom IDPE failed had been 
referred from other hospitals. As the referring surgeons 
followed IDPE treatment protocols similar to those at our 
tertiary care centre, these patients were included in the 
current study to maximize cohort size. Third, it should be 
noted that there is a difference between the infected and 
control cohorts with regards to mean duration of follow­
up (64.2 mo in the infected cohorts v. 35.4 mo in the con­
trol cohort). The control cohort was selected by matching 
patients with noninfected primary TKAs with patients in 
the infected cohort based on age and age­adjusted CCI 
scores. This process resulted in a comparable control 
cohort in terms of patient number, age, age­adjusted CCI 
and body mass index. As a result of the matching process, 
there was a difference in mean duration of follow­up 
between the cohorts. However, since previous literature 
has demonstrated that clinical outcome scores do not 
change significantly beyond 18 months after surgery,29,30 
the comparison of clinical outcomes in the cohorts is still 
relevant despite the differential follow­up. Finally, the 
data included in the current study depend on the quality 
of the data recorded in the medical records and are there­
fore subject to the limitations faced by many retrospective 
cohort designs. In some cases the onset of symptoms were 
not well recorded in terms of hours and/or days. There­
fore, although we could definitively identify that patients 
fit our definition of acute symptoms (<  4 wk), in some 
cases we were unable to reliably calculate an hour or day 
value for onset of symptoms. As a result we have not pre­
sented these data in our study.
The main strength of this study is that it offers a unique 
look at a large patient cohort experiencing a difficult compli­
cation after TKA. It also examines how different treatment 
algorithms affect patient­reported outcomes and ROM after 
treatment of infection. To our knowledge, patient­reported 
outcomes have previously not been published in the litera­
ture or been considered as part of the controversy regarding 
the appropriate management of the infected TKA.
ConClusion
There may be a role for IDPE in the treatment of peripros­
thetic infections owing to the potential for greater patient 
satisfaction with IDPE than with 2SR. The improved satis­
faction associated with a successful IDPE must be weighed 
against its lower rate of successful eradication of infection. 
By attempting to identify the patients in whom IDPE is 
most likely to succeed, a surgeon can maximize patient out­
comes when dealing with periprosthetic infection.
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